ClinicalTrials.Veeva

Menu

Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status

Enrolling

Conditions

Repetitive Stress Injury
Chronic Pain Syndrome
Chronic Pain

Treatments

Behavioral: Mind-Body Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06903962
2023P000579

Details and patient eligibility

About

The goal of this nonrandomized pilot study is to test a mind-body interventional approach for the treatment of chronic upper extremity pain or repetitive stress injury of the upper extremity (wrist/shoulder/elbow).

  1. To determine if a mind-body intervention improves upper extremity functional capacity (ie., Disability of Arm Shoulder Hand - DASH) among people with chronic wrist, elbow, and shoulder pain
  2. To determine if a mind-body intervention decreases pain intensity, pain-related anxiety, and overall somatic complaints in our trial participants.
  3. To tailor the intervention and the outcomes assessment procedures for conducting a trial in a population with upper extremity pain.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult (≥ 18 years of age)
  2. A disability score ≥ 40 as per the QuickDASH survey
  3. Presence of pain and perceived disability for a minimum of 3 months
  4. Willing to engage in a Mind-Body intervention
  5. Positive visualization test (onset of pain when patients visualize themselves performing tasks that generally bring on pain)

Exclusion criteria

  1. Clear organic diagnosis of pain (e.g., cancer, infection, etc...) not inclusive of non-specific findings on imaging studies (e.g., mild arthritis)
  2. Age greater than 60 years (due to an increased risk of there being an organic/physical cause for their pain and confounding results)
  3. Diagnosis of cognitive impairment or dementia
  4. Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation
  5. Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered in this category

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Experimental: Mind-body Intervention
Experimental group
Description:
Mind body techniques for the intervention will be taught in lectures and group discussion sessions
Treatment:
Behavioral: Mind-Body Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Samuel Kukler; Michael Donnino, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems